Impact of Self-tonometry on Glaucoma Treatment Decision.
NCT ID: NCT04888156
Last Updated: 2022-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
133 participants
OBSERVATIONAL
2021-05-10
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
iCare® Home vs Goldmann Applanation Tonometry
NCT04911387
Monitoring of the IOP After SLT Using iCare Home
NCT03310788
IOP Monitoring After Trabeculectomy Using iCare Home
NCT03445806
Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring
NCT04485897
ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer
NCT01733550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As the method is used regularly, the investigators want to evaluate the impact of self-tonometry results on the clinician's choice of glaucoma treatment. The investigators also want to evaluate how often pressure peaks occur outside the clinic's opening hours and how much they differ from GAT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GAT IOP below 15 mmHg
Glaucoma patients with an IOP measured with GAT below 15 mmHg prior performance of self-tonometry with iCare Home
Unchanged treatment
Treatment is the same pre- and post self-tonometry
Changed treatment
Treatment is changed post self-tonometry
GAT IOP equal or above 15 mmHg
Glaucoma patients with an IOP measured with GAT equal or above 15 mmHg prior performance of self-tonometry with iCare Home
Unchanged treatment
Treatment is the same pre- and post self-tonometry
Changed treatment
Treatment is changed post self-tonometry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unchanged treatment
Treatment is the same pre- and post self-tonometry
Changed treatment
Treatment is changed post self-tonometry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with POAG (primary open-angle glaucoma), PEX (pseudo-exfoliation glaucoma) or OHT (ocular hypertension)
* Difference between patients' and staff's iCare Home® measurements less than 5 mmHg at Baseline
* Difference between Goldman Applanation tonometry (GAT) and patient's highest iCare Home® measurements less than 7 mmHg at baseline
* Monitoring over at least two days
Exclusion Criteria
* Missing more than one daily measurement with iCare Home® tonometer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Erik Eye Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enping Chen
MD Ph D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enping Chen, MD PhD
Role: PRINCIPAL_INVESTIGATOR
St. Erik Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Erik Eye Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
iCare Home
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.